Clinical Trial Update: A 6-month Study to Evaluate Sulforaphane Effects in PD Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sulforaphane effects in patients with Parkinson disease is ongoing, with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Central South University | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN